# Safety of SPD465 in Treating Adults With ADHD.

> **NCT00152035** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 505 (actual)

## Conditions studied

- Attention Deficit Disorder With Hyperactivity

## Interventions

- **DRUG:** Neutral salts of dextroamphetamine sulfate, USP, amphetamine sulfate, USP, d-amphetamine saccharate, d, l-amphetamine aspartate monohydrate.

## Key facts

- **NCT ID:** NCT00152035
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03-10
- **Primary completion:** 2006-11-07
- **Final completion:** 2006-11-07
- **Target enrollment:** 505 (ACTUAL)
- **Last updated:** 2021-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00152035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00152035, "Safety of SPD465 in Treating Adults With ADHD.". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00152035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*